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ABSTRACT 
Objective: A simple, rapid, precise and accurate spectrophotometric method has been developed for determination of Flurbiprofen and 
Pantoprazole by simultaneous equation method in combined dosage form 
Methods: The 6.8 pH phosphate buffer was selected as solvent for developing spectral characteristics of both drugs. The method was validated for 
recovery studies. 
Results: The λmax of Flubiprofen was found to be 230 nm and Pantoprazole was found to be 270 nm. The method obeyed Beer’s law in the 
concentration range of 10-100 μg/ml for Flurbiprofen and 10-100 μg/ml for Pantoprazole. The percentage recovery of Flubiprofen was found to be 
99.16 and Pantoprazole was found to be 99.46. 
Conclusion: The proposed method was validated and can be used for analysis of combined tablet formulation containing Flurbiprofen and 
Pantoprazole. 
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INTRODUCTION 
Spectroscopy is the branch of science dealing with the study of 
Electro Magnetic Radiation with matter[1]. Analytical method 
validation is “the collection and evaluation of data,from the process 
design stage throughout production, which establishes scientific 
evidence that a process is capable of consistently delivering quality 
products
Flurbiprofen is a member of the phenylalkanoic acid derivative 
family of non-steroidal anti-inflammatory drugs (NSAIDs) used to 
treat the inflammation and pain of arthritis. Flurbiprofen is also 
used as an active ingredient in some kinds of throat lozenges 




Structure of Flubiprofen 
  
 
Pantoprazole; 5-(difluoro methoxy)-2-[[(3, 4 dimethoxy-2-pyridinyl) 
methyl] sulfinyl]-1H-benzimidazole, is used asantiulcer drug
Structure of Pantoprazole 
[3].  
 
Literature survey reveals that there are UV and HPLC methods 
reported for the estimation of pantoprazole in pharmaceutical 
formulations.  
The review of the literature revealed that no method is yet reported 
for the simultaneous estimation of both the drugs in combined 
dosage forms. This paper describes two simple, rapid, accurate, 
reproducible and economical methods for the simultaneous 
estimation of flurbiprofen and pantoprazole in tablet formulations 
using simultaneous equation methods. 
MATERIALS AND METHODS 
Materials 
Spectral runs were made on a Shimadzu UV-Visible 
spectrophotometer with spectral bandwidth of 0.5 nm and 
wavelength accuracy of ± 0.3 nm with automatic wavelength 
corrections with a pair of 10 mm quartz cells. 
Selection of common solvent 
The 6.8 pH phosphate buffer were selected as a common solvent for 
developing spectral characteristics of both drugs. The selection was 
made after assessing the solubility of both the drugs in different 
solvents. 
Preparation of standard stock solution 
Standard stock solutions (100 μg /ml) of Flurbiprofen and 
Pantoprazole were prepared by dissolving separately 10mg of each 
drug in ethanol and volume was added made up to 100 ml with 6.8 
pH phosphate buffer. The working standard solutions of these drugs 
were obtained by dilution of the respective stock solution with 6.8 
pH phosphate buffer. 
Analysis of pharmaceutical dosage form 
Twenty tablets were weighed accurately; average weight was 
determined and then ground to a fine powder. A quantity equivalent 
to 100 mg of Flurbiprofen and 40 mg of Pantoprazole were 
transferred to a 100 mL volumetric flask. The contents were 
ultrasonication for 10 min with 6.8 pH phosphate buffer made to 
volume and filtered through Whatmann filter paper No.41. The 
solution was further diluted with 6.8 pH phosphate buffer to give 
concentrations of 10 mcg/mL of Flurbiprofen and Pantoprazole 
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respectively. Absorbance of these solutions was measured at 230 nm 
and 270 nm as A1 and A2 respectively and concentrations of these 
two drugs in the sample were calculated using equations. 
Simultaneous equation method 
For the simultaneous equation method, 230 nm and 270 nm were 
selected as the two sampling wavelengths for Flurbiprofen and 
Pantoprazole respectively. The Flurbiprofen and Pantoprazole 
exhibited linearity in the concentration range of 10-100 μg/ml and 
10-1000 μg/ml at their respective selected wavelengths 
respectively. Coefficients of correlation were found to be 0.999 and 
0.996 for Flurbiprofen and Pantoprazole respectively. The optical 
characteristic values for the calibration curves are presented in 
Table 1. For simultaneous estimation of Flurbiprofen and 
Pantoprazole, mixed standards containing Flurbiprofen and 
Pantoprazole in a concentration ratio of 1:4 μg/ml each were 
prepared by appropriate dilution of the standard stock solutions 
with distilled water. The absorbance of the mixed standard solutions 
were measured at the selected wavelengths. The two equations were 
constructed based upon the fact that at λ1 and λ2 the absorbance of 
the mixture is the sum of individual absorbances of Flurbiprofen and 
Pantoprazole. 
At λ1, A1 = ax1bcx + ay1bcy…… (1) 
At λ2, A2 = ax2bcx + ay 2bcy…… (2) 
Where, A1 and A2 are absorbance of mixed standard at 230 nm and 
270 nm respectively. λ1 and λ2 are wavelengths of Flurbiprofen and 
Pantoprazole respectively, ax1 and ax2 are absorptivity of 
Flurbiprofen at λ1 and λ2, ay1 and ay2 are absorptivity of 
Pantoprazole at λ1 and λ2 respectively. cx and cy are concentration 
of Flurbiprofen and Pantoprazole respectively. 
Accuracy 
The accuracy of the method was established by using recovery 
experiments i. e. by external dilution method. The known amount of 
standard was added at three different levels of 80%, 100% and 
120% of sample. The percentage recoveries were calculated from 
calibration curve. The data is summarised in table 3. 
Precision 
The precision of analytical procedure expresses the closeness of 
agreement (degree of scatter) between a series of measurement 
obtained from multiple sampling of the same homogenous sample 
under the prescribed condition. Precision was determined by 
repeatability (intra-day) and intermediate precision (inter-day). 
Repeatability was evaluated by 3 determinations of 3 different 
concentrations during the same day. Intermediate precision was 
determined during 3 different days. Precision (intra-day and inter-
day) were expressed as relative standard deviation. 
Linearity 
The linearity of an analytical procedure is its ability to obtain test 
results which are directly proportional to the concentration of 
analyte in the sample. Calibration curve was constructed by plotting 
absorbance versus concentration which showed linearity over the 
concentration range of 10-100μg/ml as shown in figure 1 &2. 
Detection and quantification limits 
Limit of detection(LOD) 
The limit of detection of an individual analytical procedure is the 
lowest amount of analyte in a sample which can be detected it was 
calculated using the following formula 
LOD = 3.3σ/S 
Where, = the standard deviation of the response, S = the slope of the 
calibration curve (of the analyte) 
Limit of quantification (LOQ) 
The limit of quantification of an individual analytical procedure is the 
lowest amount of analyte in a sample which can be quantitatively 
determined. It was calculated using the following formula 
LOQ = 10σ/ S 
Where σ, =the standard deviation of the response, S=the slope of the 
calibration curve (of the analyte). 
RESULTS AND DISCUSSION 
Under the experimental conditions described, calibration curve, 
assay of tablets and recovery studies were performed. The linearity 
of Flubiprofen was found to be 10-100mcg/ml as shown in Figure 1 
and for Pantoprazole linearity was found to be 10-100msg/ml as 
shown in Figure 2. 
λ max (nm) of Flubiprofen was found to be 230 nm and for 
Pantoprazole 270 nm. The developed methods were validated as per 
ICH guidelines for linearity, repeatability, LOD, LOQ in 6.8pH Buffer 
and 0.1N HCl [5] as shown in Table 1. The mean % recovery of 
Flurbiprofen and Pantoprazole were found to be 99.16 % and 
99.47% respectively by simultaneous equation method as shown in 
Table2. The mean % content of Flurbiprofen and Pantoprazole in 
tablet formulation by the simultaneous equation method was found 
to be 99.08% and 99.9% respectively as shown in Table3. 
 
 
Fig. 1: Calibration Curve of Flubiprofen in 6.8 Buffer 
 
 
Fig. 2: Calibration Curve of Pantoprazole in 6.8 Buffer 
 
Table1: Optical Characteristics and Validation Parameters of Flurbiprofen and Pantoprazole in 6.8pH phosphate buffer 
Parameter Flurbiprofen Pantoprazole 
λ max (nm) 230 270 
Precision 0.122 0.136 
LOD (µg/ml) 4.2 3.7 
LOQ (µg/ml) 9.3 8.4 
Regression equation y=0.007x+0.022(R2 y=0.006x+0.005(R=0.998) 2=0.998) 
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Optical Characteristics and Validation Parameters of Flurbiprofen and Pantoprazole in 0.1 HCl 
Parameter Flurbiprofen Pantoprazole 
λ max (nm) 230 270 
Linearity 10-30 10-80 
Precision 0.122 0.136 
LOD (µg/ml) 4.2 3.7 
LOQ (µg/ml) 9.3 8.4 
Regression equation y=0.03x+0.001(R2 y=0.007x+0.022(R=0.999) 2=0.990) 
 
Table 2: Analysis of Pharmaceutical Dosage Form (Tablet form) 
Drug Label cliam(mg) Amount found (%) S. D. 
Flurbiprofen 100 99.16 0.12 
Pantoprazole 40 99.46 0.19 
 
Table3: Recovery data of Flurbiprofen and Pantoprazole 








80 98.25 100.08 0.91 0.31 
100 99.98 99.76 0.43 0.65 
120 99.03 99.86 0.52 0.98 
 
CONCLUSION 
A simple, rapid, precise and accurate spectrophotometric 
method has been developed for simultaneous estimation of 
Flurbiprofen and Pantoprazole by using simultaneous equation 
method. The standard deviation and RSD were found to be low, 
indicating high degree of precision of the methods. The % 
recovery was found to be occurred within a range of 98-102% 
indicating high degree of accuracy of the proposed method. The 
developed methods can be employed for the routine estimation 
of Flurbiprofen and Pantoprazole in both bulk and tablet dosage 
form. 
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